hsl-ad.com Report : Visit Site

Technical data of the hsl-ad.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host hsl-ad.com. Currently, hosted in United Kingdom and its service provider is eUKhost LTD .

the related websites

cinp.org ucl.ac.uk cancerindex.org se80.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

providing targeted cancer diagnostics publications | user info | contact ihc clinical antibodies (ihc) research antibodies (ihc) ihc & ish request forms ukneqas ish clinical probes research probes ihc & ish request forms molecular pathology digital pathology scanning service request forms image analysis algorithm list request forms clinical trials tdl trials a new division providing centralized laboratory testing, supporting clinical trials, pharma and biotech activities -- validated image analysis for accurate biomarker quantification. complete digital pathology for remote case review, teaching & research pathology dedicated team delivering lymphoma , alk , ros1 nsclc & bladder cancer fish specialist breast , gastric & lung cancer biomarker ihc testing services now available providing accredited ihc, ish, molecular & digital pathology services throughout the uk and overseas cutting edge research in next generation sequencing for personalised medicine applications highly sensitive mutation analysis service for egfr, kras & braf latest news 16/12/18 laboratory move we are pleased to inform you that from 17th december, 2018 hsl-advanced diagnostics will operate from a new laboratory at 19 fitzroy street. read more... 30/06/18 advanced diagnostics validates new ros1 ihc assay for nsclc following approval from nice to allow access to crizotonib for ros1 positive patients with nsclc, advanced diagnostics have made available a validated ros1 ihc assay to all referring clients. read more... 26/04/18 advanced diagnostics joins health services laboratories pathology joint venture organisation from the 1st may 2018 we are pleased to announce the creation of . read more... 27/10/17 advanced diagnostics are please to inform that we have received accreditation by ukas to iso15189:2012 standards advanced diagnostics are please to inform that we have received accreditation by ukas to iso15189:2012 standards. our ukas customer number is 9007 and our scope of accreditation can be found here . read more... 14/12/16 advanced diagnostics accreditation status after a successful ukas assessment on the 13th & 14th of december 2016, the advanced diagnostics laboratories are very happy to announce that we are currently "recommended for accreditation" to ukas/iso15189:2012 standards. read more... 25/08/16 pd-l1 22c3 eams reference laboratory is now offering pd-l1 ihc testing using the dako pharmdx 22c3 companion diagnostic for pembrolizumab. read more... 28/01/13 advanced diagnostics validates new alk ihc assay for nsclc advanced diagnostics validates the new roche tissue diagnostics alk ihc assay for use in non small cell lung cancer (nsclc) patients for whom crizotinib (xalkori, pfizer) is being considered. read more... 24/10/12 advanced diagnostics begins centralised testing for major clinical trial. now open for recruitment, optima is a partially-blind randomised trial designed to compare clinical and economic outcomes of standard chemotherapy treatment with biomarker-directed allocation to chemotherapy or no chemotherapy in women with er positive, her2 negative breast cancer and either axillary node involvement or larger tumours'. read more... 22/05/12 advanced diagnostics attends parliamentary briefing on targeted cancer diagnostics & personalised medicine representatives from advanced diagnostics/london cancer & bcuk attend parliamentary briefing to discuss the importance of targeted testing and personalised medicine, with a specific focus on colorectal cancer, kras testing and cetuximab. read more... 22/05/12 advanced diagnostics supports use of new roche her2 teaching resource roche unveil new her2 teaching resource. the 'her2testing' web resource supports interpretation of her2 testing in breast and gastric cancer in all areas including ihc, cish, fish and ddish and provides a valuable resource for scientists and pathologists. read more... 22/05/12 advanced diagnostics adopts roche companion diagnostics testing platform advanced diagnostics has chosen to adopt roche pathway her2 (4b5) on the benchmark ultra automated staining system for use in breast and gastric cancer her2 testing applications. read more... is a specialist clinical and research services referral laboratory and is part of the health services laboratories pathology joint venture between uclh, royal free & tdl. about us news accreditation t&cs privacy modern slavery disclaimer permissions

URL analysis for hsl-ad.com

http://www.hsl-ad.com//news/advanced-diagnostics-validates-new-ros1-ihc-assay-for-nsclc/
http://www.hsl-ad.com///accreditation/
http://www.hsl-ad.com///digital_pathology/scanning_service/
http://www.hsl-ad.com///publications/
http://www.hsl-ad.com//news/advanced-diagnostics-adopts-roche-companion-diagnostics-testing-platform/
http://www.hsl-ad.com///clinical_trials/
http://www.hsl-ad.com//news/advanced-diagnostics-validates-new-alk-ihc-assay-for-nsclc/
http://www.hsl-ad.com///ihc/clinical_antibodies/
http://www.hsl-ad.com///disclaimer/
http://www.hsl-ad.com///tdl_trials/
http://www.hsl-ad.com//news/advanced-diagnostics-attends-parliamentary-briefing-on-targeted-cancer-diagnostics-and-personalised-medicine/
http://www.hsl-ad.com///terms_and_conditions/
http://www.hsl-ad.com///contact/
http://www.hsl-ad.com///image_analysis/algorithm_list/
http://www.hsl-ad.com///digital_pathology/request_forms/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: HSL-AD.COM
Registry Domain ID: 2223667065_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.enom.com
Registrar URL: http://www.enom.com
Updated Date: 2019-01-27T14:41:26Z
Creation Date: 2018-02-06T11:05:42Z
Registry Expiry Date: 2020-02-06T11:05:42Z
Registrar: eNom, LLC
Registrar IANA ID: 48
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS5.DOMAINDEVILS.NET
Name Server: NS6.DOMAINDEVILS.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2019-08-09T02:34:37Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR eNom, LLC

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =hsl-ad.com

  PORT 43

  TYPE domain

DOMAIN

  NAME hsl-ad.com

  CHANGED 2019-01-27

  CREATED 2018-02-06

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS5.DOMAINDEVILS.NET 109.203.110.64

  NS6.DOMAINDEVILS.NET 109.203.110.65

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .